Investigating the effect of melatonin use versus placebo on delirium in patients admitted to the intensive care unit
Phase 3
- Conditions
- delirium.Other deliriumF05.8
- Registration Number
- IRCT20240429061595N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Age 18 and above
written and informed consent from the patient's legal guardian
Exclusion Criteria
Allergy to melatonin
intestinal obstruction
gastroparesis
side absorption
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of delirium. Timepoint: 4 days after the intervention. Method of measurement: examination.
- Secondary Outcome Measures
Name Time Method